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Conclusion 
	   This	   study	   reveals	   the	   circula4on	  of	   toxigenic	  C.	  diﬃcile	  strains	  among	  diﬀerent	   types	  of	  pa4ents	   in	  a	   Spanish	  hospital.	  
Most	   of	   the	   isolates	  were	   obtained	   from	  pa4ents	  without	   acute/bloody	   diarrhea.	   The	   survey	   of	   the	   epidemiology	   of	  C.	  
diﬃcile	   shows	  a	  wide	  heterogeneity	  of	   the	  ribotypes,	   the	  absance	  of	  clonal	  spread	  within	  wards	  and	  that	  most	   frequent	  
ribotypes	  mirror	  those	  found	  in	  the	  surveillance	  program	  in	  other	  European	  countries,	  including	  in	  Belgium.	  	  
Introduction 
	   Increasing	   age,	   several	   co-­‐morbidi4es,	   environmental	   contamina4on,	   an4bio4c	   exposure	   and	   other	   intes4nal	  
perturba4ons	   appear	   to	   be	   the	   greatest	   risk	   factors	   for	   C.	   diﬃcile	   infec4on	   (CDI).	   Therefore,	   hospitalized	   pa4ents	   are	  
considered	  par4culary	  vulnerable	  to	  CDI.	  The	  main	  objec4ve	  of	  this	  study	  was	  to	  evaluate	  the	  prevalence	  of	  C.	  diﬃcile	  in	  a	  
Spanish	  hospital	  and	  to	  characterize	  the	  isolates	  with	  respect	  to	  PCR-­‐ribotype,	  an4bio4c	  resistance	  and	  toxin	  ac4vity.	  
Sampling 
	  The	  study	  was	  conducted	  in	  a	  1,324-­‐bed	  
Central	   University	   Hospital	   (HUCA)	   in	  
Oviedo,	  Spain.	  During	  a	  4-­‐month	  period,	  
from	   July	   to	   October	   2014,	   all	   pa4ents	  
(hospitalised	   pa4ents	   or	   outpa4ents	   in	  
consulta4on)	  suspected	  to	  have	  CDI	  were	  
eligible	   to	   par4cipate.	   Stools	   were	  
received	   in	   the	   rou4ne	   coprology	  
laboratory	  of	  the	  HUCA.	  
	  
C. difficile analysis 
	   First	   screening	   for	   C.	   diﬃcile	   was	  
performed	   using	   a	   rapid	   membrane	  
e n z yme	   immuno a s s a y	   f o r	   t h e	  
silmutaneus	   detec4on	   of	   C.	   diﬃcile	  
glutamate	   dehydrogenase	   an4gen	   and	  
toxins	   A	   and	   B	   (Cdiﬀ	   QuickChek	  
Complete®	   TechLab).	   At	   the	   same	   4me	  
fresh	   stool	   samples	   were	   cultured	   on	  
home-­‐made	   selec4ve	   medium	   CCFAT	  
directly	   and	  a\er	  an	  enrichment	   step	  of	  
3	  days	  in	  the	  same	  liquid	  media. 
 
Molecular characterization 
	  Iden4ﬁca4on	  and	  characteriza4on	  of	  the	  
colonies	   were	   done	   by	   detec4on	   of	   tpi,	  
tcdA,	   tcdB	   and	   cdtA	   genes.	   GenomEra	  
CDX	   System	   C.	   diﬃcile	   (Abacus)	   was	  
performed	   for	   the	  rapid	   iden4ﬁca4on	  of	  
toxin	   B.	   Further	   characteriza4on	   was	  
performed	   by	   PCR-­‐ribotyping	   and	  
Genotype	   Cdiﬀ	   test	   (Hain	   Lifescience)	  
which	   detects	   dele4ons	   in	   the	   regulator	  
gene	  tcdC	  and	  gyrA	  muta4ons	  associated	  
with	  moxiﬂoxacin	  resistance.	  
 
PCR-ribotype analysis 
	   Proﬁles	   were	   analyzed	   by	   comparison	  
with	   those	  of	   reference	  strains	   from	  the	  
European	  Brazier	  collec4on	  and	  with	  our	  

















	   Suscep4bil ity	   to	   metronidazole,	  
moxiﬂoxacin	   and	   tetracycline	   was	  
determined	   by	   Etest	   strips	   (Lucron	  
EliTech	   Group)	   on	   Brucella	   Blood	   Agar	  
with	   hemin	   and	   vitamin	   K1	   (Becton-­‐
Dickinson)	   according	   to	   the	   instruc4ons	  
of	   the	   manufactured.	   Plates	   were	  
anaerobically	   incubated	  at	  37°C	  for	  48H.	  
The	   resistance	   (r)	   breakpoints	   for	  
metronidazole	   (MET	   r≥	   32	   μg/ml)	   and	  
tetracycline	   (Tet	   r≥	  8	  μg/ml)	  were	   those	  
recommended	   by	   the	   Clinical	   and	  
Laboratory	   Standard	   Ins4tute	   (CLSI).	  
Bacteroides	  fragilis	  ATCL	  was	  included	  as	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Clos	  +	   Clos	  -­‐	  
Results 
	   Culture	  was	  posi4ve	   in	   32	   stools	   from	  
261	  posi4ve	  samples	  (prevalence	  8.1%).	  
Most	  of	  the	  posi4ve	  samples	  were	  from	  
pa4ents	   older	   tha	   60	   years	   (Figure	   1).	  
We	   could	   diﬀerenciate	   18	   diﬀerent	  
ribotypes.	   Seventeen	   of	   them	   were	  





C.	  diﬃcile	  detec%on	  
Figure	  1.	  	  
Characteris4cs	  of	  C.	  diﬃcile	  cases	  
Table	  1.	  	  
C.	  diﬃcile	  ribotypes	  in	  hospitalized	  pa4ents	  and	  an4microbial	  resistance	  of	  the	  isolates	  	  
